Sort   by:  
 Page size 
UnknownEfavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine.
Not available
S-EPMC9890454 | biostudies-literature
UnknownRisk-stratified treatment for drug-susceptible pulmonary tuberculosis.
Not available
S-EPMC11526018 | biostudies-literature
UnknownFour-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.
Not available
S-EPMC8282329 | biostudies-literature
UnknownWhole genomes redefine the mutational landscape of pancreatic cancer.
Not available
S-EPMC4523082 | biostudies-literature
UnknownThe deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma.
Not available
S-EPMC3376394 | biostudies-literature
UnknownHNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer.
Not available
S-EPMC9511995 | biostudies-literature
UnknownTargeting DNA Damage Response and Replication Stress in Pancreatic Cancer.
Not available
S-EPMC8167930 | biostudies-literature
UnknownPancreatic cancer genomes reveal aberrations in axon guidance pathway genes.
Not available
S-EPMC3530898 | biostudies-literature
UnknownValidation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery.
Not available
S-EPMC8855527 | biostudies-literature
Sort   by:  
 Page size